Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
Intratumoral heterogeneity (ITH) refers to the presence of distinct tumor cell populations. It provides vital information for the clinical prognosis, drug responsiveness, and personalized treatment of cancer patients. As genomic ITH in various cancers affects the expression patterns of genes, the ex...
Main Authors: | Ji-Yong Sung, Hyun-Tae Shin, Kyung-Ah Sohn, Soo-Yong Shin, Woong-Yang Park, Je-Gun Joung |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0219682 |
Similar Items
-
Intratumoral heterogeneity
by: Filip Vuletić, et al.
Published: (2018-02-01) -
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
by: Xia Zhang, et al.
Published: (2020-11-01) -
Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer.
by: Anne Haahr Mellergaard Eriksen, et al.
Published: (2016-01-01) -
Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
by: Gustav Stålhammar, et al.
Published: (2021-03-01) -
Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
by: Shin Hye Yoo, et al.
Published: (2021-01-01)